EMEA-002532-PIP01-18-M01
Key facts
| Active substance |
Phenobarbital
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0301/2021
|
| PIP number |
EMEA-002532-PIP01-18-M01
|
| Pharmaceutical form(s) |
Oral suspension
|
| Condition(s) / indication(s) |
Treatment of epilepsy
|
| Route(s) of administration |
|
| Contact for public enquiries |
Proveca Pharma Limited
E-mail: info@proveca.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|